ANATech

NMR Technologies for Glucose Monitoring

Health Tech & Life Sciences
Non Active, Nov 2016
Follow

Company Overview

Snapshot

Founded in January 2012 by David Keini, ANATech operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on research and development for non-invasive medical devices.

Business overview

ANATech specializes in developing solutions based on nuclear magnetic resonance (NMR) technologies and signal-processing algorithms. The company's core focus is on creating compact, affordable devices to address real-world problems and enhance quality of life. ANATech is actively engaged in a significant R&D project to develop a non-invasive blood glucose and viscosity measurement device, targeting both clinical and home applications within the Health Tech & Life Sciences sector, specifically in medical devices and monitoring.

Log in to access full profile

Company Intelligence Q&A

What is ANATech's primary focus?
ANATech focuses on developing solutions utilizing nuclear magnetic resonance technologies and signal-processing algorithms to create compact and affordable medical devices.
What specific product is ANATech currently developing?
ANATech is engaged in a major R&D project to develop a non-invasive blood glucose and viscosity measurement device for both clinical and home use.
When was ANATech founded?
ANATech was founded in January 2012.
Who founded ANATech?
David Keini is the founder of ANATech.
In which sector does ANATech primarily operate?
ANATech operates within the Health Tech & Life Sciences sector, with a focus on medical devices and monitoring.
Log in to access full profile